Robert Huff, MD
Ophthalmology · Columbia, SCNPI 1134157779
Payments from drug & device makers
Across 506 payments — averaging $24.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$3K
- AbbVie$2K
- Sun Pharmaceutical Industries Inc.$2K
- Bausch & Lomb Americas Inc.$736
- Novartis$589
- Johnson & Johnson Surgical Vision, Inc.$517
- plus $4K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 98 | $2,880 |
| AbbVie(2 entities) | 70 | $2,092 |
| Sun Pharmaceutical Industries Inc. | 88 | $1,540 |
| Bausch & Lomb Americas Inc. | 31 | $736 |
| Novartis | 26 | $589 |
| Johnson & Johnson Surgical Vision, Inc. | 14 | $517 |
| Mallinckrodt Hospital Products Inc. | 16 | $415 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 31 | $408 |
| Kala Pharmaceuticals, Inc. | 18 | $388 |
| Glaukos Corporation | 7 | $358 |
| Ocular Therapeutix, Inc. | 11 | $318 |
| Sight Sciences, Inc. | 17 | $316 |
| NEW World Medical,inc. | 4 | $285 |
| Oyster Point Pharma, Inc. | 13 | $260 |
| Tarsus Pharmaceuticals, Inc. | 10 | $249 |
| Rayner Intraocular Lenses Limited | 13 | $225 |
| Amgen(2 entities) | 9 | $165 |
| Omeros Corporation | 2 | $140 |
| Harrow Eye, LLC | 6 | $124 |
| Thea Pharma Inc. | 4 | $124 |
| Optos, Inc. | 1 | $65 |
| Mallinckrodt Enterprises LLC | 3 | $54 |
| Eyevance Pharmaceuticals LLC | 3 | $51 |
| Lensar, Inc. | 1 | $43 |
| Shire North American Group Inc | 3 | $37 |
| Dompe US, Inc. | 1 | $29 |
| Rxsight Inc | 1 | $26 |
| Eyepoint US, Inc. | 1 | $19 |
| Carl Zeiss Meditec USA, Inc. | 1 | $17 |
| Akorn, Inc. | 1 | $16 |
| Maculogix, Inc. | 1 | $14 |
| Apellis Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$12,510 in reported general payments places this provider in the 85th percentile of 293 ophthalmology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Columbia
- Matthew ClaryColumbia$123K
- Willard HarmsColumbia$14K
- Stephen CrossColumbia$11K
- Ryan MercerColumbia$9K
- John WellsWest Columbia$7.1M
- William ClarkWest Columbia$6.2M
- Daniel AlfaroCharleston$4.6M
- Kerry SolomonMt Pleasant$4.6M
- Eric JablonCharleston$1.2M
- George WaringMt Pleasant$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.